Bellevue Group Ag Roivant Sciences Ltd. Transaction History
Bellevue Group Ag
- $5.02 Billion
- Q4 2024
A detailed history of Bellevue Group Ag transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Bellevue Group Ag holds 24,000 shares of ROIV stock, worth $256,080. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,000Holding current value
$256,080% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$702 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$662 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$510 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$470 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$377 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.52B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...